Status:
COMPLETED
The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery
Lead Sponsor:
Mansoura University
Conditions:
Post-Surgical Complication
Breast Cancer Surgery
Eligibility:
FEMALE
18-65 years
Phase:
PHASE2
Brief Summary
The goal of this clinical trial is to assess the efficacy of pentoxifylline in reducing postsurgical complications for breast cancer patients undergoing breast cancer surgery. It aims to evaluate the ...
Detailed Description
The goal of this clinical trial is to assess the efficacy of pentoxifylline in reducing postsurgical complications for breast cancer patients undergoing mastectomy. It aims to evaluate the efficacy o...
Eligibility Criteria
Inclusion
- Adult female patients aged 18 to 65 years
- Patients completed neoadjuvant chemotherapy cycles and scheduled for breast cancer surgery.
Exclusion
- Patients on treatment regimen of phosphodiesterase inhibitors
- Patients who are taking antiplatelet or anticoagulant treatment
- Patients who are allergic to phosphodiesterase inhibitors
- History of recent hemorrhagic events
- Active peptic ulcer
- History of psychological problems
- History of chronic pain management
- Pregnancy or breastfeeding
Key Trial Info
Start Date :
October 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT06087237
Start Date
October 30 2023
End Date
June 30 2024
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oncology center of Mansoura University
Al Mansurah, Egypt